Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-026136
Filing Date
2022-07-15
Accepted
2022-07-15 17:45:11
Documents
2
Period of Report
2022-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1628
2 EX-24 DOCUMENT attachment1.htm EX-24 4753
  Complete submission text file 0000899243-22-026136.txt   8017
Mailing Address C/O SENTI BIOSCIENCES, INC. 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Rajangam Kanya (Reporting) CIK: 0001816676 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40440 | Film No.: 221087733

Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Issuer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)